Price $8.14 |
Market Cap
2.78B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
-
|
P/S
0.36
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-728K
|
FCF
-2.6
|
|
Op. Margin
16.40%
|
Net Margin
-2.80%
|
ROE
42.30%
|
ROI
6.20%
|
|
ROA
-0.80%
|
EPS Growth
76.60%
|
Current Ratio
1.1
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Jounce Therapeutics Inc (JNCE) | $1.88 | - | - | 96.8M | Strong Buy |
| Equillium Inc (EQ) | $0.64 | - | - | 24.9M | Strong Buy |
| Emmaus Life Sciences Inc (EMMA) | $0.31 | - | - | 16.4M | Strong Buy |
| Mallinckrodt PLC (MNK) | $3.00 | - | - | 97.2M | Strong Buy |
| Medicine Man Technologies Inc (SHWZ) | $1.01 | - | - | 59.4M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
